Inauguration of the streaming sessions for the CSIC Science Week 2020 from the IIBB

They are free registrations available (aimed at high school students or equivalent, but not exclusive).

Read More

The PhD student Sara Figuerola has published a scientific dissemination video about stroke

The researcher Sara Figuerola explains the studies on the remodeling of the microvasculature by perivascular macrophages after a stroke which are part of the ENTRAIN CONSORTIUM and the Cerebrovascular Research Group of the IIBB-CSIC, led by Dr. Anna M Planas. Her research activity is funded through a project of the Horizon2020 program of the European Union.

Read More

IIBB-CSIC researchers participate in a study that has obtained promising results for the treatment of Huntington's disease in experimental models

Innovative optogenetic stimulation technique uses bursts of blue light to activate selectively neurons

The study has identified a neural circuit involved in the development of this genetic disease

Read More


A new study by the Cerebrovascular Research group of the IIBB-CSIC, in collaboration with scientists from CNIC in Madrid and the Universitätsklinikum Hamburg-Eppendorf in Hamburg, has identified peculiarities and specific functions of the dendritic cells that infiltrate the brain after an ischemic stroke.

Read More

Discovered a new cellular defense mechanism against viral and bacterial infections

An international team with the participation of the Institute of Biomedical Research of Barcelona (IIBB-CSIC) has described a new immune defense mechanism orchestrated by lipid droplets, as cellular organelles capable of attracting and eliminating invading pathogens. The results are published in the latest issue of Science.

Read More

Scientific progress in COVID-19: identification of genetic and immune causes that explain the disparity of severity of symptoms

Science journal publishes two scientific articles (12)  that contribute to explain the highly variable response among the population to the disease caused by SARS-CoV-2, known as COVID-19.

Read More

EBioMedicine journal (The Lancet) publishes and highlights this month a study on Parkinson's disease carried out by researchers from the IIBB-CSIC

Work led by Dr. Analia Bortolozzi has shown a possible new drug target to alleviate early deficiencies in dopamine function in Parkinson's disease. The results have been confirmed in mice and elderly non-human primates, paving the way to be transferred to humans.

Read More